Skip to content

Aurora Biliary Stent System

by Medtronic Ave, Inc.

510(k) K030839

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESU Special NumberK030839 Date30 May 2003ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Medtronic Ave Bridge Aurora Biliary Stent System (Aurora)
510(k) Number
FDA Product Code
FGE
Device Class
Class II
Regulation
21 CFR Part 876.5010
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESU

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Aurora Biliary Stent System is a self-expanding, tubular nitinol stent designed for biliary duct drainage. It is classified as a stent, drain, and dilator for the biliary ducts and is intended to palliate obstructions caused by malignant neoplasms within the biliary tree. The device features radiopaque markers for fluoroscopic guidance during placement.

This system is delivered transhepatically via a sheathed delivery catheter and is intended for single-use. It is constructed from biocompatible materials and is regulated under FDA 510(k) clearance (K030839) as a Class II device (regulation number 876.5010). The stent is supplied sterile and is intended for use in clinical settings such as endoscopy or interventional radiology.

Other devices from Medtronic Ave, Inc.

See all devices from Medtronic Ave, Inc. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical scenarios is the Aurora Biliary Stent System intended to address specifically within biliary drainage procedures?

    The Aurora Biliary Stent System is designed to palliate obstructions caused by malignant neoplasms (cancers) within the biliary tree, which are the ducts responsible for transporting bile from the liver to the small intestine. It is intended for biliary duct drainage to relieve blockages that can lead to conditions like cholestasis or jaundice in patients with malignant biliary strictures.

  • How is the Aurora Biliary Stent System delivered, and what type of procedural setting is it intended for?

    The Aurora Biliary Stent System is delivered transhepatically via a sheathed delivery catheter, meaning it is inserted through the liver into the biliary ducts. It is intended for use in clinical settings such as endoscopy or interventional radiology, where fluoroscopic guidance is available to assist with precise placement.

  • Is the Aurora Biliary Stent System reusable, or is it intended for single-use only?

    The Aurora Biliary Stent System is explicitly intended for single-use only, as stated in its design and regulatory documentation. This ensures patient safety and sterility, as it is supplied sterile and not meant to be reused.

  • What materials is the Aurora Biliary Stent System constructed from, and why does this matter?

    The Aurora Biliary Stent System is constructed from biocompatible materials, which means they are designed to be safe for use within the human body without causing adverse reactions. This is particularly important for long-term drainage applications, as biocompatibility reduces the risk of inflammation, infection, or other complications.

  • What regulatory pathway was followed for the Aurora Biliary Stent System, and what does this mean for its use?

    The Aurora Biliary Stent System was cleared through the FDA’s 510(k) pathway, specifically under clearance number K030839, and is classified as a Class II device under regulation number 876.5010. This means it has undergone a premarket submission process to demonstrate substantial equivalence to a legally marketed predicate device, ensuring it meets FDA safety and effectiveness standards for its intended use in biliary drainage.